Is Finger Cancer a Thing? Signs, Types, and Treatment

Cancer can and does develop in the fingers, though it is genuinely rare. In one review of 402 hand tumors, only about 2.5% turned out to be malignant, with the rest being harmless growths like ganglion cysts and giant cell tumors.¹ Still, nearly every tissue in a finger — skin, nail bed, bone, cartilage, soft tissue — can give rise to a malignancy, and these tumors are notorious for being mistaken for warts, infections, or minor injuries, sometimes for years before anyone orders a biopsy.

How Common Is Finger Cancer, Really

The overwhelming majority of lumps, bumps, and lesions that show up on a finger are benign. Ganglion cysts, giant cell tumors, and enchondromas (small, harmless cartilage growths inside bone) account for the bulk of what hand surgeons see. Malignant tumors in the hand are rare compared to benign ones, though surgeons stress the importance of being able to recognize them because the consequences of a missed diagnosis are serious.² In the large Turkish review mentioned above, soft tissue cancers made up about 1.6% of all soft tissue hand tumors, and malignant bone tumors were a slightly higher proportion of their smaller bone-tumor category.¹ In practical terms, a finger growth is far more likely to be harmless than cancerous, but “rare” is not the same as “impossible.”

Skin Cancers That Can Develop on a Finger

Squamous Cell Carcinoma

Squamous cell carcinoma is the most common malignancy of the nail unit and one of the most frequently reported skin cancers on the fingers overall.³ It typically starts beneath or beside the nail plate and grows slowly. Because it can look like a stubborn wart, a fungal infection, or chronic nail damage, clinicians sometimes call it “the great mimicker.” Clinical signs include separation of the nail from its bed, redness, and — in more advanced cases — ulceration and pain that hints at invasion into the underlying bone.³

Squamous cell carcinoma on the palmar side of the fingertips is even more unusual but has been documented. Risk factors include carcinogen exposure, a weakened immune system, prior radiation to the hand, trauma, and infection with human papillomavirus (HPV).⁴ The HPV connection is worth knowing about: high-risk HPV subtypes — the same ones linked to cervical and genital cancers — have been found in squamous cell carcinomas of the fingers in both people with healthy immune systems and those who are immunosuppressed.⁵ One analysis found HPV 16 DNA actively expressed in finger squamous cell carcinomas, suggesting the virus plays a direct role rather than being an innocent bystander.⁶ A case report described an HIV-positive man with rare HPV type 26 who developed multiple invasive squamous cell carcinomas across several fingernails, underscoring how immunosuppression and HPV can compound the risk.⁷

A detail that catches many people off guard: nail-associated squamous cell carcinomas tied to HPV have a higher rate of coming back after removal than squamous cell carcinomas in other skin locations.⁵ Stubborn periungual warts caused by high-risk HPV subtypes are worth taking seriously, even if they look minor.

Subungual Melanoma

Melanoma beneath the nail (subungual melanoma) is the cancer most people picture when they think of finger cancer, though it is rarer than squamous cell carcinoma in this location. It often shows up as a dark streak running from the cuticle to the tip of the nail. Signs that raise suspicion include a streak that widens over time, uneven pigmentation, splitting or distortion of the nail, and the Hutchinson sign — pigment that spills beyond the nail onto the surrounding skin folds.⁸ The Hutchinson sign has traditionally been linked to a worse prognosis because it indicates the melanoma is spreading outward.

Subungual melanoma does not always produce pigmentation, though. It can present as nail splitting or bleeding from the nail bed without any obvious dark streak, which is one reason it often gets missed or attributed to injury.⁹ Unlike typical cutaneous melanoma, subungual melanoma is not strongly tied to sun exposure, and it occurs across all skin tones. It disproportionately affects people with darker skin, for whom it represents a larger share of melanoma diagnoses overall.

Basal Cell Carcinoma

Basal cell carcinoma is the most common skin cancer in general, but finding one on a finger is a genuine oddity. It overwhelmingly favors sun-drenched areas like the face and neck, so finger involvement has only been reported in scattered case studies. When it does appear on a finger, the thumb seems to be the most frequent site, and the nodular subtype is the most common variant.¹⁰ Established risk factors for this unusual presentation include sun exposure, scarring, immunosuppression, and occupational injuries like thermal burns.¹⁰ One reported case involved a 77-year-old woman with a nine-month history of a lesion on the back of her index finger.¹¹ If you spot a pearly or ulcerated nodule on a finger that does not heal, it is worth having a dermatologist look at it, even though the odds of BCC are low.

Bone and Soft Tissue Cancers in the Fingers

Chondrosarcoma

Enchondromas — benign cartilage tumors inside the finger bones — are among the most common bone tumors in the hand. Chondrosarcoma, their malignant counterpart, is far rarer. Both tend to appear in the proximal phalanx (the bone closest to the knuckle), which has led to speculation that some chondrosarcomas arise from pre-existing enchondromas. However, a study of 35 cases found histologic or clinical evidence of that transformation in only about 14% of patients, and the authors characterized malignant transformation as a very rare event given how common benign enchondromas are.¹² Phalangeal chondrosarcoma tends to be locally aggressive but slow to spread to distant sites, so limb-sparing surgery rather than amputation is often the goal.

Epithelioid Sarcoma

Epithelioid sarcoma is a rare soft tissue cancer that has a particular affinity for the distal upper extremity — the hand, fingers, and forearm. It tends to strike younger adults and grow slowly, starting as a small, firm nodule under the skin that can easily be dismissed as a cyst or scar tissue.¹³ That innocent appearance is what makes it dangerous: because it does not look alarming early on, patients and clinicians sometimes delay biopsy, and the tumor has time to extend along tendons and nerves. In one study of classic-type epithelioid sarcoma in the distal upper extremity, the wrist was the most commonly affected site, followed by the metacarpal area and then the fingers.¹⁴ The tumor has a well-documented tendency to recur locally and to spread to lymph nodes and distant organs, which is unusual for soft tissue sarcomas and makes early detection all the more important.¹³

When Cancer From Elsewhere Reaches a Finger

Sometimes a tumor in a finger is not finger cancer at all — it is a metastasis from a cancer elsewhere in the body. Bone metastases occur in roughly a third of all cancers, yet only a small fraction of those metastases land in the hand.¹⁵ Lung cancer is the most common primary source, followed by breast and kidney cancers.¹⁶ The middle finger and the tip (distal phalanx) are the areas most often affected, and the presentation is maddeningly vague — swelling, pain, and redness that could be mistaken for an infection or gout.¹⁶ In some reported cases, a sore, swollen finger was the very first sign of an undiagnosed lung cancer.¹⁵

Warning Signs Worth Checking

No single symptom shouts “cancer” in the fingers, but certain patterns should push you toward a medical evaluation sooner rather than later:

A dark nail streak: A longitudinal pigmented band that changes width, grows unevenly, or produces pigment on the surrounding skin raises concern for subungual melanoma.
A stubborn wart: A wart-like growth around or under the nail that resists standard treatments and persists for months could be squamous cell carcinoma in disguise.
Nail lifting or destruction: Chronic separation of the nail plate from the nail bed, especially with redness or bleeding, may signal an underlying malignancy rather than a fungal infection.
A slow-growing nodule: A firm, painless lump under the skin of a finger or hand that slowly enlarges over months should be biopsied, particularly in a younger adult, to rule out epithelioid sarcoma.
Unexplained bone pain and swelling: Finger pain and swelling that do not respond to antibiotics or anti-inflammatory treatment and that show a bone abnormality on X-ray warrant further imaging and biopsy.
A non-healing ulcer: Any sore on a finger that will not heal after several weeks, especially in someone with a history of radiation exposure, chronic wounds, or immunosuppression.

Pain, swelling, and inflammation alongside a nail lesion in particular tend to indicate that a squamous cell carcinoma has already grown into bone.³ The earlier these signs are investigated, the more tissue — and function — can be saved.

Why Finger Cancers Are So Often Misdiagnosed

Diagnostic delays are the rule, not the exception, with finger malignancies. Subungual melanoma presents in a more disguised manner than melanoma on regular skin, and increased vigilance is needed because it most commonly shows up as nail discoloration, splitting, or bleeding — all things that get attributed to injury or fungal infection.⁹ Squamous cell carcinoma earns its “great mimicker” label by masquerading as a chronic wart or eczema for months or years. Epithelioid sarcoma gets mistaken for a ganglion cyst, a deep callus, or even a healing wound.¹³ And bone metastases to the fingers are so unexpected that imaging is rarely ordered until the symptoms fail to respond to treatment for infection or arthritis.

Systemic conditions like sarcoidosis, intraosseous cysts, and infections can mimic primary bone tumors on imaging, adding another layer of diagnostic confusion.¹⁷ The practical takeaway is that any finger lesion — whether skin, nail, or bone — that persists or progresses despite appropriate treatment deserves a biopsy, not just another round of medication.

How Finger Cancers Are Diagnosed

Biopsy is the definitive step. For subungual and periungual lesions, there are several approaches: a punch biopsy through or around the nail, a shave biopsy, or a full excisional biopsy depending on the size and location of the growth.¹⁸ For solid subungual tumors, imaging alone is generally not enough to distinguish benign from malignant growths, so biopsy is recommended as the first step in managing any solid lesion under or beside a nail. Even lesions that initially look infectious should be biopsied promptly if they do not clear up with appropriate treatment, and clinicians have suggested aiming for no more than eight weeks between a patient’s first visit and a tissue diagnosis for any subungual mass.¹⁹

MRI can play a useful role once a diagnosis is suspected or confirmed. In squamous cell carcinoma of the nail, MRI helps map the tumor’s extent, determine whether it has invaded bone or the surrounding skin folds, and guide the surgeon’s approach. The imaging can differentiate between in-situ disease (limited to the outermost layer) and invasive cancer, with the deeper margin of the tumor looking well-defined in early-stage cases and blurred in invasive ones.²⁰

Treatment Options

Treatment depends heavily on the tumor type, its stage, and how much tissue is involved. For squamous cell carcinoma of the nail, Mohs surgery — a technique where thin layers of tissue are removed and examined under a microscope one at a time — allows surgeons to clear the cancer with narrow margins, preserving as much of the finger as possible. In a series of 15 patients treated with Mohs surgery as the first approach, the tumor was completely removed in 13, while only two required amputation of the fingertip.²¹ That track record makes a compelling case for early detection: the smaller the cancer at the time of surgery, the better the chances of keeping the finger intact.

For melanoma of the finger, treatment typically involves amputation at or above the affected joint, often combined with chemotherapy and immunotherapy. In a study of 22 patients with finger melanoma, all underwent finger amputation, and over half also had lymph node dissection on the same side.²² The combined approach of surgery plus systemic therapy reflects the fact that melanoma is more likely to spread beyond its origin than squamous cell carcinoma.

For soft tissue sarcomas of the hand, there has been a shift toward limb-sparing surgery wherever oncologically safe, because long-term survival rates are similar whether the finger is amputated or reconstructed.²³ Reconstruction is more complex and involves more operations, radiation or chemotherapy, and a longer rehabilitation period, but it allows patients to keep meaningful hand function. Bone tumors like chondrosarcoma are usually treated with wide excision or curettage, with amputation reserved for cases where the tumor is too extensive for limb-sparing approaches.

Reconstruction and Functional Recovery

When part of a finger or an entire ray (the finger plus its corresponding metacarpal bone) must be removed, several reconstructive techniques are available. Ray transposition involves shifting an adjacent finger into the gap left by the removed ray, which can produce an acceptable functional result, though it sometimes looks unusual cosmetically.²⁴ Other techniques include free tissue transfers and skin flaps from the groin or other donor sites. In soft tissue sarcoma cases, one study found that patients who underwent limb salvage and reconstruction retained an average of about 75% of normal hand function.²³ With proper preoperative planning, over 95% of upper extremity tumor cases can achieve some form of limb salvage that preserves function, sensation, and wound stability.²⁵

Custom-made, 3D-printed prosthetic implants are an emerging option for patients who have had finger or hand bones removed. In a study of patients who received these implants after tumor resection, the median functional score was 28 out of 30, though complications were common — including joint stiffness, implant loosening, and stem breakage — with roughly a third of patients experiencing implant failure within five years.²⁶ The technology is promising but still maturing. Aggressive rehabilitation after any reconstructive procedure — proper splinting and early guided motion — is consistently emphasized as critical to getting the best long-term result.²⁵

The Psychological Side of Losing Part of a Finger

Discussions about finger cancer tend to focus on survival and surgical technique, but the emotional toll of losing part of a hand is substantial and often underestimated. Hands are how we interact with the world — physically, socially, through gesture and touch. Losing a finger or part of one affects body image, grip strength, fine motor skills, and the ability to perform job-related tasks. Upper extremity amputees experience psychological disturbances at a rate roughly 50% to 100% higher than people who lose part of a lower limb, driven by the combined impact of functional loss, persistent pain, and visible deformity in a highly social body part.²⁷

This does not mean life after finger amputation is bleak — most people adapt impressively, especially with occupational therapy and peer support — but it means that the psychological dimension should be part of the treatment conversation from the beginning, not an afterthought once the wound has healed. Surgeons increasingly recognize that the measure of a successful outcome is not just whether the cancer is gone, but whether the patient’s hand still works well enough to let them live the life they want.

1
Turkish Journal of Pathology. Tumorous Conditions of the Hand: A Retrospective Review of 402 Cases
2
Journal of the American Academy of Orthopaedic Surgeons. Malignant Tumors of the Hand
3
PubMed Central. Squamous cell carcinoma of the nail unit
4
PubMed Central. Finger Pad Squamous Cell Carcinoma: Report of Squamous Cell Carcinoma of the Distal Palmar Digit and Review of Associated Risk Factors, Mimickers, and Treatment of Squamous Cell Carcinoma of Ventral Hand Digits
5
Journal of the American Academy of Dermatology. Ungual and periungual human papillomavirus–associated squamous cell carcinoma: A review
6
PubMed. Possible role for human papillomavirus 16 in squamous cell carcinoma of the finger
7
British Journal of Dermatology. Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy
8
Actas Dermo-Sifiliográficas. Is Hutchinson’s Sign Pathognomonic of Subungual Melanoma?
9
PubMed Central. Missed opportunity to diagnose subungual melanoma: potential pitfalls!
10
PubMed Central. Uncommon Manifestation of Basal Cell Carcinoma on the Fingers: A Case Report and Review of the Existing Literature
11
PubMed Central. Basal Cell Carcinoma of the 2nd Digit Treated With the Reverse Cross-Finger Flap: A Case Report
12
Cancer. Chondrosarcoma of the phalanx: A locally aggressive lesion with minimal metastatic potential
13
PubMed Central. Epithelioid sarcoma: a review and update
14
PubMed Central. Classic Type of Epithelioid Sarcoma of the Distal Upper Extremity: Clinical and Oncological Characteristics
15
PubMed Central. Digital Acrometastasis as Initial Presentation in Carcinoma of Lung A Case Report and Review of Literature
16
PubMed Central. Two cases of acrometastasis to the hands and review of the literature
17
PubMed. Diagnostic imaging of benign and malignant osseous tumors of the fingers
18
PubMed Central. Nail Biopsy: A User’s Manual
19
The Journal of Hand Surgery. Subungual Tumors: An Algorithmic Approach
20
PubMed. MRI of squamous cell carcinoma of the nail apparatus: report of 6 cases
21
British Journal of Dermatology. Mohs surgery for squamous cell carcinoma of the nail: report of 15 cases
22
PubMed Central. Clinical features of malignant melanoma of the finger and therapeutic efficacies of different treatments
23
PubMed Central. Soft tissue sarcomas of the hand: functional reconstruction and outcome analysis
24
PubMed. Primary reconstruction with digital ray transposition after resection of malignant tumor
25
PubMed. Reconstruction of the hand and upper extremity after tumor resection
26
PubMed Central. What Are the MSTS Scores and Complications Associated With the Use of Three-dimensional Printed, Custom-made Prostheses in Patients Who Had Resection of Tumors of the Hand and Foot?
27
PubMed Central. The Psychological and Somatic Consequences of Digital Amputation